4//SEC Filing
Treco Douglas A 4
Accession 0001209191-23-022649
CIK 0001693011other
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:05 PM ET
Size
12.7 KB
Accession
0001209191-23-022649
Insider Transaction Report
Form 4
Treco Douglas A
DirectorCEO & Chairman
Transactions
- Award
Restricted stock units
2023-04-01+100,000→ 100,000 total→ Common stock (100,000 underlying) - Award
Stock option (right to buy)
2023-04-01+800,000→ 800,000 totalExercise: $5.73Exp: 2033-03-31→ Common stock (800,000 underlying)
Footnotes (3)
- [F1]The exercise price represents the closing price of the Issuer's common stock on March 31, 2023.
- [F2]The option was granted on April 1, 2023 and is scheduled to vest in equal monthly installments until the fourth anniversary of the grant date.
- [F3]The restricted stock units were granted on April 1, 2023. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The restricted stock units vest in equal annual installments on each anniversary of the grant date until the fourth anniversary of the grant date.
Issuer
Inozyme Pharma, Inc.
CIK 0001693011
Entity typeother
Related Parties
1- filerCIK 0001688192
Filing Metadata
- Form type
- 4
- Filed
- Apr 3, 8:00 PM ET
- Accepted
- Apr 4, 4:05 PM ET
- Size
- 12.7 KB